Mkts

Teva Pharmaceutical Industries Limited

NYSE: TEVA
$42.09+0.62 (+1.50%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
41.1742.59
52-week range
6,207.0013,070.00
Today
Open41.17
Previous close42.09
Volume—
Valuation
Market cap148.23B
P/E ratio67.00×
EPS (TTM)0.60
Income & risk
Dividend / yield—
Beta0.49
Avg volume1.06M
Discussion

TEVA News

Stories mentioning TEVA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue3,982,0001,500,0004,480,0004,176,0003,891,0004,229,0004,332,0004,164,000
Cost of Goods Sold2,011,0002,056,0002,176,0002,074,0002,014,0002,110,0002,183,0002,140,000
Gross Profit1,972,0002,655,0002,304,0002,102,0001,877,0002,121,0002,148,0002,024,000
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)652,000301,000882,000455,000519,000(29,000)(51,000)(5,000)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision67,000(390,000)214,000(78,000)74,00029,00069,000630,000
Net Income (Loss)369,000481,000433,000282,000214,000(217,000)(437,000)(846,000)
Earnings Per Share (Basic)0.320.420.380.250.19(0.19)(0.39)(0.75)
Earnings Per Share (Diluted)0.310.410.370.240.18(0.19)(0.39)(0.75)
Weighted Average Shares Outstanding (Basic)1,156,0001,145,0001,147,0001,147,0001,138,0001,131,0001,133,0001,133,000
Weighted Average Shares Outstanding (Diluted)1,179,0001,163,0001,164,0001,161,0001,159,0001,131,0001,133,0001,133,000

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TEVA

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a stock listed on the New York Stock Exchange under the ticker symbol TEVA. It last traded at $42.09 (Oct 30, 2026, 4:00 PM ET), up 1.5% on the day. That gives Teva Pharmaceutical Industries a market capitalisation of $148.2B and a price-to-earnings ratio of 67.0.

Over the past 52 weeks TEVA has traded between $6,207.00 and $13,070.00.

Revenue for the quarter ended Mar 31, 2026 was $4.0B; net income $369.0M. Revenue was up 2.3% from $3.9B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$4.0B$369.0M9.3%
Dec 31, 2025$1.5B$481.0M32.1%
Sep 30, 2025$4.5B$433.0M9.7%
Jun 30, 2025$4.2B$282.0M6.8%

From Teva Pharmaceutical Industries’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…